Table III.
Kyoto Encyclopedia of Genes and Genomes pathways enriched by overlapping genes between differentially expressed genes and differentially methylated genes.
| Pathway ID | Description | P-value | Corrected P-value |
|---|---|---|---|
| hsa00350 | Tyrosine metabolism | 1.30×10−6 | 1.27×10−4 |
| hsa00010 | Glycolysis/gluconeogenesis | 1.46×10−5 | 7.14×10−4 |
| hsa05204 | Chemical carcinogenesis | 3.11×10−5 | 1.02×10−3 |
| hsa01100 | Metabolic pathways | 2.51×10−4 | 6.14×10−3 |
| hsa00830 | Retinol metabolism | 3.82×10−4 | 7.39×10−3 |
| hsa00982 | Drug metabolism-cytochrome P450 | 4.52×10−4 | 7.39×10−3 |
| hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.30×10−4 | 7.42×10−3 |
| hsa05323 | Rheumatoid arthritis | 9.84×10−4 | 1.21×10−2 |
| hsa05146 | Amoebiasis | 1.28×10−3 | 1.40×10−2 |
| hsa04668 | TNF signaling pathway | 1.67×10−3 | 1.64×10−2 |
| hsa05219 | Bladder cancer | 3.58×10−3 | 3.19×10−2 |
| hsa00071 | Fatty acid degradation | 4.08×10−3 | 3.34×10−2 |
| hsa05202 | Transcriptional misregulation in cancer | 6.47×10−3 | 4.64×10−2 |
| hsa05150 | Staphylococcus aureus infection | 6.64×10−3 | 4.64×10−2 |
| hsa04062 | Chemokine signaling pathway | 7.17×10−3 | 4.69×10−2 |